Hepatitis C Virus Protease Inhibitors

被引：2
|
作者：
Abdel-Magid, Ahmed F. [1 ]
机构：
[1] Therachem Res Medilab India Pvt Ltd, Jaipur, Rajasthan, India
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2012年 / 3卷 / 09期
关键词：
D O I：
10.1021/ml300199d
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：699 / 700
页数：2
相关论文
共 50 条
  • [41] The quest for hepatitis C virus NS3 serine protease inhibitors.
    Tur-Kaspa, R
    Berdichevsky, Y
    Zemel, R
    Bachmatov, L
    Lamed, R
    HEPATOLOGY, 2000, 32 (04) : 562A - 562A
  • [42] Molecular docking of peptide inhibitors to the hepatitis C virus NS3 protease
    Shenderovich, M
    Wang, J
    Fisher, C
    Ramnarayan, K
    Abagyan, R
    PEPTIDES FOR THE NEW MILLENNIUM, 2000, : 472 - 473
  • [43] Variability and resistance mutations in the hepatitis C virus NS3 protease in patients not treated with protease inhibitors
    Zeminian, Luciana Bonome
    Padovani, Juliana Lara
    Corvino, Silvia Maria
    Silva, Giovanni Faria
    de Moura Campos Pardini, Maria Ines
    Tommasini Grotto, Rejane Maria
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2013, 108 (01): : 13 - 17
  • [44] Advances in the Development of Macrocyclic Inhibitors of Hepatitis C Virus NS3-4A Protease
    Avolio, Salvatore
    Summa, Vincenzo
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (14) : 1403 - 1422
  • [45] Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large US cohort
    Backus, L. I.
    Belperio, P. S.
    Shahoumian, T. A.
    Cheung, R.
    Mole, L. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (01) : 93 - 103
  • [46] Discovery of novel phosphonate derivatives as hepatitis C virus NS3 protease inhibitors
    Sheng, X. Christopher
    Pyun, Hyung-Jung
    Chaudhary, Kleem
    Wang, Jianying
    Doerffler, Edward
    Fleury, Melissa
    McMurtrie, Darren
    Chen, Xiaowu
    Delaney, William E.
    Kim, Choung U.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (13) : 3453 - 3457
  • [47] α-ketoacids are potent slow binding inhibitors of the hepatitis C virus NS3 protease
    Narjes, F
    Brunetti, M
    Colarusso, S
    Gerlach, B
    Koch, U
    Biasiol, G
    Fattori, D
    De Francesco, R
    Matassa, VG
    Steinkühler, C
    BIOCHEMISTRY, 2000, 39 (07) : 1849 - 1861
  • [48] Cell-based assay for inhibitors of Hepatitis C Virus NS3 protease
    Chung, V
    D'Souza, E
    Carroll, AR
    ANTIVIRAL RESEARCH, 2002, 53 (03) : A73 - A73
  • [49] The role of triple therapy with protease inhibitors in hepatitis C virus genotype 1 naive patients
    Nelson, David R.
    LIVER INTERNATIONAL, 2011, 31 : 53 - 57
  • [50] Pharmacokinetic/Pharmacodynamic Predictors of Clinical Potency for Hepatitis C Virus Nonnucleoside Polymerase and Protease Inhibitors
    Reddy, Micaela B.
    Morcos, Peter N.
    Le Pogam, Sophie
    Ou, Ying
    Frank, Karl
    Lave, Thierry
    Smith, Patrick
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (06) : 3144 - 3156
12345